agilon health (NYSE:AGL) Shares Gap Down – What’s Next?

agilon health, inc. (NYSE:AGL)’s share price gapped down prior to trading on Tuesday . The stock had previously closed at $2.26, but opened at $2.19. agilon health shares last traded at $2.13, with a volume of 99,490 shares.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on AGL shares. Evercore ISI decreased their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Citigroup reduced their price objective on shares of agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research report on Wednesday, November 13th. Benchmark restated a “buy” rating and set a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. Stifel Nicolaus reduced their price objective on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research report on Tuesday, November 12th. Finally, TD Cowen reduced their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Three investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, agilon health currently has a consensus rating of “Hold” and an average price target of $6.05.

agilon health Stock Performance

The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a market capitalization of $826.10 million, a price-to-earnings ratio of -2.22 and a beta of 0.60. The stock’s 50 day moving average price is $2.86 and its two-hundred day moving average price is $4.72.

agilon health (NYSE:AGL) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same quarter in the prior year, the firm earned ($0.06) earnings per share. On average, analysts forecast that agilon health, inc. will post -0.47 EPS for the current year.

Insider Buying and Selling

In other news, CEO Steven Sell purchased 20,000 shares of the stock in a transaction dated Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This represents a 42.03 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. increased its stake in agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after purchasing an additional 371,537 shares during the last quarter. State Street Corp increased its stake in agilon health by 3.0% during the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after purchasing an additional 215,733 shares during the last quarter. Geode Capital Management LLC increased its stake in agilon health by 1.2% during the third quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock valued at $27,097,000 after purchasing an additional 84,889 shares during the last quarter. Citigroup Inc. increased its stake in agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the last quarter. Finally, AQR Capital Management LLC increased its stake in agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after purchasing an additional 1,316,990 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.